Publications
28 found
Show per page
Petrelli, Francesco, Zehnder, Tamara, Laugeray, Anthony, Mondoloni, Sarah, Calì, Corrado, Pucci, Luca, Molinero Perez, Alicia, Bondiolotti, Bianca Maria, De Oliveira Figueiredo, Eva, Dallerac, Glenn, Déglon, Nicole, Giros, Bruno, Magrassi, Lorenzo, Mothet, Jean-Pierre, Mameli, Manuel, Biological Psychiatry, 93(11), 966–975. https://doi.org/10.1016/j.biopsych.2022.11.018
, & Bezzi, Paola. (2023). Disruption of Astrocyte-Dependent Dopamine Control in the Developing Medial Prefrontal Cortex Leads to Excessive Grooming in Mice.
Petrelli, Francesco, Zehnder, Tamara, Laugeray, Anthony, Mondoloni, Sarah, Calì, Corrado, Pucci, Luca, Molinero Perez, Alicia, Bondiolotti, Bianca Maria, De Oliveira Figueiredo, Eva, Dallerac, Glenn, Déglon, Nicole, Giros, Bruno, Magrassi, Lorenzo, Mothet, Jean-Pierre, Mameli, Manuel, Biological Psychiatry, 93(11), 966–975. https://doi.org/10.1016/j.biopsych.2022.11.018
, & Bezzi, Paola. (2023). Disruption of Astrocyte-Dependent Dopamine Control in the Developing Medial Prefrontal Cortex Leads to Excessive Grooming in Mice.
Nature, 608(7922), 368–373. https://doi.org/10.1038/s41586-022-04993-7
, Li, Yue, Hadjas, Lotfi C, Hiver, Agnès, van Zessen, Ruud, & Lüscher, Christian. (2022). Dual action of ketamine confines addiction liability.
Nature, 608(7922), 368–373. https://doi.org/10.1038/s41586-022-04993-7
, Li, Yue, Hadjas, Lotfi C, Hiver, Agnès, van Zessen, Ruud, & Lüscher, Christian. (2022). Dual action of ketamine confines addiction liability.
Davis, Gwynne L, Minerva, Adelaide R, Lario, Argentina, Nature Communications, 12(1), 6040. https://doi.org/10.1038/s41467-021-26247-2
, Rodriguez, Carolyn I, & Gunaydin, Lisa A. (2021). Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice.
Davis, Gwynne L, Minerva, Adelaide R, Lario, Argentina, Nature Communications, 12(1), 6040. https://doi.org/10.1038/s41467-021-26247-2
, Rodriguez, Carolyn I, & Gunaydin, Lisa A. (2021). Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice.
Li, Yue, Science, 373(6560), 1252–1256. https://doi.org/10.1126/science.abi9086
, Van Zessen, Ruud, Flakowski, Jérôme, Wan, Jin-Xia, Deng, Fei, Li, Yu-Long, Nautiyal, Katherine M, Pascoli, Vincent, & Lüscher, Christian. (2021). Synaptic mechanism underlying serotonin modulation of transition to cocaine addiction.
Li, Yue, Science, 373(6560), 1252–1256. https://doi.org/10.1126/science.abi9086
, Van Zessen, Ruud, Flakowski, Jérôme, Wan, Jin-Xia, Deng, Fei, Li, Yu-Long, Nautiyal, Katherine M, Pascoli, Vincent, & Lüscher, Christian. (2021). Synaptic mechanism underlying serotonin modulation of transition to cocaine addiction.
Hadjas, Lotfi C, Schartner, Michael M, Cand, Jennifer, Creed, Meaghan C, Pascoli, Vincent, Lüscher, Christian, & Neuropsychopharmacology, 45(12), 2020–2029. https://doi.org/10.1038/s41386-020-0747-3
. (2020). Projection-specific deficits in synaptic transmission in adult Sapap3-knockout mice.
Hadjas, Lotfi C, Schartner, Michael M, Cand, Jennifer, Creed, Meaghan C, Pascoli, Vincent, Lüscher, Christian, & Neuropsychopharmacology, 45(12), 2020–2029. https://doi.org/10.1038/s41386-020-0747-3
. (2020). Projection-specific deficits in synaptic transmission in adult Sapap3-knockout mice.
Hadjas, Lotfi C, Lüscher, Christian, & Scientific Reports, 9(1), 12061. https://doi.org/10.1038/s41598-019-48637-9
. (2019). Aberrant habit formation in the Sapap3-knockout mouse model of obsessive-compulsive disorder.
Hadjas, Lotfi C, Lüscher, Christian, & Scientific Reports, 9(1), 12061. https://doi.org/10.1038/s41598-019-48637-9
. (2019). Aberrant habit formation in the Sapap3-knockout mouse model of obsessive-compulsive disorder.
ACS Chemical Neuroscience, 10(7), 3053–3060. https://doi.org/10.1021/acschemneuro.9b00005
, & Blakely, Randy D. (2019). The SERT Met172 Mouse: An Engineered Model To Elucidate the Contributions of Serotonin Signaling to Cocaine Action.
ACS Chemical Neuroscience, 10(7), 3053–3060. https://doi.org/10.1021/acschemneuro.9b00005
, & Blakely, Randy D. (2019). The SERT Met172 Mouse: An Engineered Model To Elucidate the Contributions of Serotonin Signaling to Cocaine Action.
Neurochemistry International, 129, 104464. https://doi.org/10.1016/j.neuint.2019.104464
, & Ozawa, Takaaki. (2019). Neural circuits in goal-directed and habitual behavior: Implications for circuit dysfunction in obsessive-compulsive disorder.
Neurochemistry International, 129, 104464. https://doi.org/10.1016/j.neuint.2019.104464
, & Ozawa, Takaaki. (2019). Neural circuits in goal-directed and habitual behavior: Implications for circuit dysfunction in obsessive-compulsive disorder.
Handbook of experimental pharmacology, 252, 143–164. https://doi.org/10.1007/164_2018_113
, & Liechti, Matthias E. (2018). Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
Handbook of experimental pharmacology, 252, 143–164. https://doi.org/10.1007/164_2018_113
, & Liechti, Matthias E. (2018). Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
Nackenoff, Alex G, ACS Chemical Neuroscience, 8(5), 1092–1100. https://doi.org/10.1021/acschemneuro.7b00038
, Baganz, Nicole L, Pehrson, Alan L, Sánchez, Connie, & Blakely, Randy D. (2017). Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
Nackenoff, Alex G, ACS Chemical Neuroscience, 8(5), 1092–1100. https://doi.org/10.1021/acschemneuro.7b00038
, Baganz, Nicole L, Pehrson, Alan L, Sánchez, Connie, & Blakely, Randy D. (2017). Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
British Journal of Pharmacology, 174(16), 2716–2738. https://doi.org/10.1111/bph.13899
, Anacker, Allison M J, Levin, Michael H, Vaswani, Nina M, Gresch, Paul J, Nackenoff, Alex G, Anastasio, Noelle C, Stutz, Sonja J, Cunningham, Kathryn A, Wang, Jing, Zhang, Bing, Henry, L Keith, Stewart, Adele, Veenstra-VanderWeele, Jeremy, & Blakely, Randy D. (2017). Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine.
British Journal of Pharmacology, 174(16), 2716–2738. https://doi.org/10.1111/bph.13899
, Anacker, Allison M J, Levin, Michael H, Vaswani, Nina M, Gresch, Paul J, Nackenoff, Alex G, Anastasio, Noelle C, Stutz, Sonja J, Cunningham, Kathryn A, Wang, Jing, Zhang, Bing, Henry, L Keith, Stewart, Adele, Veenstra-VanderWeele, Jeremy, & Blakely, Randy D. (2017). Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine.
Current Topics in Behavioral Neurosciences, 32, 49–72. https://doi.org/10.1007/7854_2016_20
, & Liechti, Matthias E. (2017). Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.
Current Topics in Behavioral Neurosciences, 32, 49–72. https://doi.org/10.1007/7854_2016_20
, & Liechti, Matthias E. (2017). Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.
The Journal of Pharmacology and Experimental Therapeutics, 357(1), 134–144. https://doi.org/10.1124/jpet.115.229765
, Buchy, Danièle, Chaboz, Sylvie, Hoener, Marius C., & Liechti, Matthias E. (2016). In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1.
The Journal of Pharmacology and Experimental Therapeutics, 357(1), 134–144. https://doi.org/10.1124/jpet.115.229765
, Buchy, Danièle, Chaboz, Sylvie, Hoener, Marius C., & Liechti, Matthias E. (2016). In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1.
Hysek, C. M., Schmid, Y., Social cognitive and affective neuroscience, 9(11), 1645–1652. https://doi.org/10.1093/scan/nst161
, Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E. (2014). MDMA enhances emotional empathy and prosocial behavior.
Hysek, C. M., Schmid, Y., Social cognitive and affective neuroscience, 9(11), 1645–1652. https://doi.org/10.1093/scan/nst161
, Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E. (2014). MDMA enhances emotional empathy and prosocial behavior.
Hysek, C. M., International journal of neuropsychopharmacology, 17(3), 371–381. https://doi.org/10.1017/s1461145713001132
, Schillinger, N., Meyer, N., Schmid, Y., Donzelli, M., Grouzmann, E., & Liechti, M. E. (2014). Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.
Hysek, C. M., International journal of neuropsychopharmacology, 17(3), 371–381. https://doi.org/10.1017/s1461145713001132
, Schillinger, N., Meyer, N., Schmid, Y., Donzelli, M., Grouzmann, E., & Liechti, M. E. (2014). Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.
Schmid, Yasmin, Hysek, Cédric M., Journal of psychopharmacology, 28(9), 847–856. https://doi.org/10.1177/0269881114542454
, Crockett, Molly J., Quednow, Boris B., & Liechti, Matthias E. (2014). Differential effects of MDMA and methylphenidate on social cognition.
Schmid, Yasmin, Hysek, Cédric M., Journal of psychopharmacology, 28(9), 847–856. https://doi.org/10.1177/0269881114542454
, Crockett, Molly J., Quednow, Boris B., & Liechti, Matthias E. (2014). Differential effects of MDMA and methylphenidate on social cognition.
Neuropharmacology, 79, 152–160. https://doi.org/10.1016/j.neuropharm.2013.11.008
, Rickli, A., Hoener, M. C., & Liechti, M. E. (2014). Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.
Neuropharmacology, 79, 152–160. https://doi.org/10.1016/j.neuropharm.2013.11.008
, Rickli, A., Hoener, M. C., & Liechti, M. E. (2014). Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.
Biochemical Pharmacology, 88(2), 237–244. https://doi.org/10.1016/j.bcp.2014.01.024
, Rickli, Anna, Schramm, York, Hoener, Marius C., & Liechti, Matthias E. (2014). Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives.
Biochemical Pharmacology, 88(2), 237–244. https://doi.org/10.1016/j.bcp.2014.01.024
, Rickli, Anna, Schramm, York, Hoener, Marius C., & Liechti, Matthias E. (2014). Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives.
Vollbrecht, Peter J, Journal of Neurochemistry, 130(1), 109–114. https://doi.org/10.1111/jnc.12697
, Blakely, Randy D, & Deutch, Ariel Y. (2014). Dopamine denervation of the prefrontal cortex increases expression of the astrocytic glutamate transporter GLT-1.
Vollbrecht, Peter J, Journal of Neurochemistry, 130(1), 109–114. https://doi.org/10.1111/jnc.12697
, Blakely, Randy D, & Deutch, Ariel Y. (2014). Dopamine denervation of the prefrontal cortex increases expression of the astrocytic glutamate transporter GLT-1.
Hysek, C. M., Fink, A. E., Journal of Clinical Psychopharmacology, Vol. 33, H. 5, 658–666. https://doi.org/10.1097/jcp.0b013e3182979d32
, Donzelli, M., Grouzmann, E., & Liechti, M. E. (2013). a-Adrenergic receptors contribute to the acute effects of MDMA in humans.
Hysek, C. M., Fink, A. E., Journal of Clinical Psychopharmacology, Vol. 33, H. 5, 658–666. https://doi.org/10.1097/jcp.0b013e3182979d32
, Donzelli, M., Grouzmann, E., & Liechti, M. E. (2013). a-Adrenergic receptors contribute to the acute effects of MDMA in humans.
BMC Research Notes, 6, 220. https://doi.org/10.1186/1756-0500-6-220
, Wandeler, Rebecca, & Liechti, Matthias E. (2013). Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence.
BMC Research Notes, 6, 220. https://doi.org/10.1186/1756-0500-6-220
, Wandeler, Rebecca, & Liechti, Matthias E. (2013). Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence.
Hysek, C. M., Brugger, R., Journal of Pharmacology and Experimental Therapeutics, Vol. 340, H. 2, 286–294. https://doi.org/10.1124/jpet.111.188425
, Bruggisser, M., Donzelli, M., Grouzmann, E., Hoener, M. C., & Liechti, M. E. (2012). Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.
Hysek, C. M., Brugger, R., Journal of Pharmacology and Experimental Therapeutics, Vol. 340, H. 2, 286–294. https://doi.org/10.1124/jpet.111.188425
, Bruggisser, M., Donzelli, M., Grouzmann, E., Hoener, M. C., & Liechti, M. E. (2012). Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.
Hysek, C. M., PLoS ONE, 7(5). https://doi.org/10.1371/journal.pone.0036476
, Nicola, V. G., Vischer, N., Donzelli, M., Krahenbuhl, S., Grouzmann, E., Huwyler, J., Hoener, M. C., & Liechti, M. E. (2012). Duloxetine inhibits effects of MDMA (“ecstasy”) in vitro and in humans in a randomized placebo-controlled laboratory study.
Hysek, C. M., PLoS ONE, 7(5). https://doi.org/10.1371/journal.pone.0036476
, Nicola, V. G., Vischer, N., Donzelli, M., Krahenbuhl, S., Grouzmann, E., Huwyler, J., Hoener, M. C., & Liechti, M. E. (2012). Duloxetine inhibits effects of MDMA (“ecstasy”) in vitro and in humans in a randomized placebo-controlled laboratory study.
Hysek, C., Schmid, Y., Rickli, A., British Journal of Pharmacology, 166(8), 2277–2288. https://doi.org/10.1111/j.1476-5381.2012.01936.x
, Donzelli, M., Grouzmann, E., & Liechti, M. E. (2012). Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.
Hysek, C., Schmid, Y., Rickli, A., British Journal of Pharmacology, 166(8), 2277–2288. https://doi.org/10.1111/j.1476-5381.2012.01936.x
, Donzelli, M., Grouzmann, E., & Liechti, M. E. (2012). Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.
British Journal of Pharmacology, 168(2), 458–470. https://doi.org/10.1111/j.1476-5381.2012.02145.x
, Buser, T. A., Donzelli, M., Schramm, Y., Dieu, L. H., Huwyler, J., Chaboz, S., Hoener, M. C., & Liechti, M. E. (2012). Pharmacological characterization of designer cathinones in vitro.
British Journal of Pharmacology, 168(2), 458–470. https://doi.org/10.1111/j.1476-5381.2012.02145.x
, Buser, T. A., Donzelli, M., Schramm, Y., Dieu, L. H., Huwyler, J., Chaboz, S., Hoener, M. C., & Liechti, M. E. (2012). Pharmacological characterization of designer cathinones in vitro.
Hysek, C. M., Clinical Pharmacology and Therapeutics, 90(2), 246–255. https://doi.org/10.1038/clpt.2011.78
, Ineichen, M., Grouzmann, E., Hoener, M. C., Brenneisen, R., Huwyler, J., & Liechti, M. E. (2011). The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans.
Hysek, C. M., Clinical Pharmacology and Therapeutics, 90(2), 246–255. https://doi.org/10.1038/clpt.2011.78
, Ineichen, M., Grouzmann, E., Hoener, M. C., Brenneisen, R., Huwyler, J., & Liechti, M. E. (2011). The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans.
Journal of clinical endocrinology and metabolism, 96(9), 2844–2850. https://doi.org/10.1210/jc.2011-1143
, Hysek, C. M., & Liechti, M. E. (2011). Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.
Journal of clinical endocrinology and metabolism, 96(9), 2844–2850. https://doi.org/10.1210/jc.2011-1143
, Hysek, C. M., & Liechti, M. E. (2011). Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.
Vejnovic, Ivana, International Journal of Pharmaceutics, 386(1-2), 185–194. https://doi.org/10.1016/j.ijpharm.2009.11.019
, & Betz, Gabriele. (2010). Investigation of different formulations for drug delivery through the nail plate.
Vejnovic, Ivana, International Journal of Pharmaceutics, 386(1-2), 185–194. https://doi.org/10.1016/j.ijpharm.2009.11.019
, & Betz, Gabriele. (2010). Investigation of different formulations for drug delivery through the nail plate.